Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ImmuneWatch Logo
ImmuneWatch CB Rank
729318
Heat Score
63
ImmuneWatch is a biotechnology company that develops T-cell based therapeutics and diagnostics.
Founded
obfuscation
Private Antwerp, Antwerpen, Belgium1-10 www.immunewatch.com
Biotechnology
Health Diagnostics
Therapeutics
Overview

ImmuneWatch
Heat Score
63

Growth Score
pts
in past quarter
Heat Score 63
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ImmuneWatch

CB Rank
729318
ImmuneWatch is a biotechnology company that develops T-cell based therapeutics and diagnostics.
Founded
obfuscation
Private Antwerp, Antwerpen, Belgium1-10 www.immunewatch.com
Biotechnology
Health Diagnostics
Therapeutics

Key People

Details

Legal Name ImmuneWatch BV
Operating Status Active
Company Type For Profit
Founders  Kris Laukens, Pieter Meysman, Sander Wuyts
Contact Email business@immunewatch.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ImmuneWatch DETECT
A machine learning platform that annotates the epitope specificity of T-cell receptor sequences to identify therapy-, vaccine-, or pathogen-specific TCRs from TCR repertoires.
ImmuneWatch DESIGN
A reverse vaccinology pipeline that predicts and ranks immunogenic T cell epitopes and antigens from protein or genome sequences for vaccine development.

Research & Development

ImmuneWatch is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 1

Employee Profiles

News

News and Press

News•Nov 30, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 30, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

120
-58.9%
 in past month

IT Spend

$208.9KThis year, ImmuneWatch is projected to spend $208.9K on IT, according to Aberdeen.

Active Website Tech Count

4ImmuneWatch is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, Person Schema, and  Gravatar Profiles.
Sub-Organizations
Frequently Asked Questions

Where is ImmuneWatch's headquarters? ImmuneWatch is located in Antwerp, Antwerpen, Belgium.Who are ImmuneWatch's competitors? Alternatives and possible competitors to ImmuneWatch may include TScan Therapeutics, Benchling, and  Adaptive Biotechnologies.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|